Poster Abstractsyield generated from sequencing. Our results indicate that the DNApolymerase from the KAPA SYBR Fast kit is better suited to libraryquantification applications while the Roche SYBR Green kit showedsignificant variability, possibly related to sample type or insert size.No differences were observed between the two types <strong>of</strong> standardsused, making DNA polymerase the determining factor in the successfulamplification <strong>of</strong> each library.**149 A New Sequencing Primer andWorkflow Increase 5’ Resolution andThroughput on HLA SequencingJ. Chuu 1 , S.C. Hung 1 , S. Berosik 1 , M. Wenz 1 ,S. Schneider 1 , P. Ma 1 , D. Berchanskiy 2 , D. Dinauer 21Life Technologies, Foster City, CA, United States;2Life Technologies, Brown Deer, WI, United StatesHigh quality and high accuracy are the hallmarks <strong>of</strong> Sanger resequencingprojects. We have developed a new sequencing primer andworkflow that improves 5’ sequence resolution, increases throughput,and reduces hands-on time. The novel sequencing primer chemistryproduces high quality bases from base 1 on POP-7TM polymer thatpreviously only could be resolved on the slower POP-6TM polymer.The new primer chemistry and workflow also eliminates the needfor a separate PCR clean-up step. These improvements reduce theentire workflow from PCR to finished sequence data to under 5hours, compared to 8 hours for the standard workflow. We used ourenhanced sequencing primer and workflow to investigate feasibilityon Human Leukocyte Antigen (HLA) polymorphisms on twelve DNAsamples by using the Invitrogen SeCore® HLA-DRB1 primer set andGroup Specific Sequencing Primers. Sequencing reactions generatedwith the traditional sequencing primer and with the new sequencingprimer were electrophoresed on Applied Biosystems 3500xl GeneticAnalyzer using POP-7TM polymer. For each sequencing primer, wecompared 5’ resolution and basecalling accuracy and quality. Onaverage the traditional primers produced high quality readablebases by base 25 after the sequencing primer while the new primersproduced high quality bases by base 5, and by base 1 in many cases.Because <strong>of</strong> improved resolution, basecalling accuracy was increased.This simplified process without a separate PCR clean-up step reducedthe overall workflow time by 40%. For HLA genes, obtaining readablesequence within 5 bases <strong>of</strong> the primer <strong>of</strong>fers improved polymorphismdetection and more efficient use <strong>of</strong> allele specific sequencing primersfor heterozygous ambiguity resolution. In conclusion, the novel primerchemistry and workflow generates data superior in quality relative toother currently used solutions and <strong>of</strong>fers significant time savings as well.Specific applications <strong>of</strong> this product are under development and notintended for clinical use.150 ScriptSeq RNA-Seq LibraryPreparation Method: A SimplifiedWork-Flow for Directional NGS RNA-Seq Library Preparation with Whole-Transcript RepresentationA. Khanna 1 , R. Sooknanan 2 , J. Hitchen 2 , A. Radek 21Epicentre BIOtechnologies, Madison, WI, UnitedStates; 2 RiboTherapeutics Inc., Saint Laurent, QC,CanadaRNA sequencing is an emerging revolutionary tool for wholetranscriptomeanalysis that provides information about the structure<strong>of</strong> transcripts and their expression levels. Current methods for makingsequencer-specific di-tagged DNA fragment libraries for RNA-Seqtypically comprise preparing rRNA-depleted RNAand either (i) RNAfragmentation, 5’ and 3’ adaptor-ligation, size selection, cDNA synthesis,and multiple clean-up steps; or (ii) cDNA synthesis followed by cDNAfragmentation, end-polishing, 5’ and 3’ adaptor-ligation, size selectionand multiple clean-up steps. These methods are generally long andrequire significant hands-on time. We describe a novel protocol thatutilizes a unique Terminal-Tagging technology that simplifies thepreparation <strong>of</strong> directional RNA-Seq libraries from rRNA-depleted orpoly(A)-enriched RNAin about 3 hours, without the need for adaptorligation, cDNA nebulization or gel purification. The di-tagged cDNAfragments that are generated from this simple, single tube protocolare compatible with different NGS sequencing platforms. Apart fromits simplicity, another major strength <strong>of</strong> this RNA-seq protocol is itsability to determine the polarity <strong>of</strong> the RNA transcripts, which is criticalfor the annotation <strong>of</strong> novel genes. Sequencing results obtained fromlibraries prepared by using RiboZeroTM rRNA-depletion method andScriptSeq mRNA-Seq Library Preparation Method show excellentdirectionality with less than 2 % <strong>of</strong> the sequence reads that map torRNA sequences (28S, 18S, 5.8S and 5S). This reduction in rRNAsequence reads improves sequence depth and coverage, and increasesthe percentage <strong>of</strong> uniquely mapped reads. Further, there is a highcorrelation (R2=0.9235) between differentially expressed transcriptsfound in the ScriptSeq RNA-Seq libraries and the MAQC QPCR panel<strong>of</strong> genes.151 The Agilent Technologies’SureSelect TM All Exon ProductPortfolio: High Performance TargetEnrichment System for Human andMouse Exome Sequencing on Illuminaand SOLiD PlatformsH. Ravi, A. Giuffre, C. Pabón-Peña, B. Novak,S. Joshi, J. Ong , M. Visitacion, M. Hamady,F. Useche, J. Eberle, S. Hunt, S. Happe, D. Roberts,E. LeproustAgilent Technologies, Stratagene Products Division,Cedar Creek, TX, United StatesThe dramatic increase in throughput <strong>of</strong> sequencing data from nextgenerationsequencing platforms has enabled scientists to study thegenome with unprecedented depth and accuracy. Nevertheless, routinegenetic screens in large numbers <strong>of</strong> individuals continue to remain costprohibitivethrough these approaches. Agilent Technologies’ SureSelectplatform for targeted exome capture, combined with massively parallelsequencing, provides a more affordable method to gain novel insightsinto the genetic causes <strong>of</strong> inherited disorders. In addition, identification<strong>of</strong> both common and rare polymorphisms implicated in complexdiseases like cancer is greatly facilitated by selectively sequencing theprotein-coding regions <strong>of</strong> the genome. In collaboration with the Broadand Sanger Institutes, Agilent Technologies has continued to expandthe number <strong>of</strong> SureSelect target enrichment catalog products in orderto enable a more comprehensive view <strong>of</strong> the protein-coding regionsin humans and model organisms. We discuss the SureSelectHuman AllExon v2 (44Mb) and SureSelectHuman All Exon 50Mb designs. We alsointroduce the SureSelectMouse All Exon target enrichment system,which improves the ability to study genetic variation between strains ingreater detail, and significantly increases the efficiency <strong>of</strong> screening forcausative mutations in N-ethyl-N-nitrosourea (ENU)-mutagenized mice.We demonstrate high performance with respect to capture efficiency,74 • <strong>ABRF</strong> <strong>2011</strong> — Technologies to Enable Personalized Medicine
uniformity, reproducibility <strong>of</strong> enrichment, and ability to detect SNPs,insertion/deletions, and CNVs across Illumina (Genome Analyzer IIxand HiSeq2000) and SOLiD platforms. We highlight the utility <strong>of</strong> theSureSelect All Exon product portfolio for a wide variety <strong>of</strong> applicationsprimarily due to the high specificity and excellent cross-platformsequence coverage. SureSelect All Exon designs also provide a meansfor standardization, consistency <strong>of</strong> performance, and reliability acrossmultiple laboratories.152 PCR-Free Nextera Di-TaggedDNA Library Preparation for NGSApplicationsC. Kinross, H. Grunenwald, B. Baas, I. Goryshin,N. Caruccio, M. MaffittEpicentre Biotechnologies, Madison, WI, UnitedStatesThe Nextera TM technology for generating libraries <strong>of</strong> di-tagged DNAfragments is rapidly becoming the preferred method for massivelyparallel DNA sequencing. Despite rapid advances in sequencinginstrument throughput, classic library preparation by step-wise ligation<strong>of</strong> adaptors is a time-intensive and throughput-limiting bottleneck.PCR amplification <strong>of</strong> libraries prior to cluster generation is also amajor concern because <strong>of</strong> its possibility to reduce library complexity,particularly in regions <strong>of</strong> extreme G+C content (high or low), therebyproducing uneven genome coverage and confounding mapping andassembly. In this study, we describe novel modifications <strong>of</strong> the Nextera TMlibrary preparation system to address such library preparation biasby eliminating PCR amplification. Sequencer-ready libraries can beobtained from as little as 200 ng <strong>of</strong> genomic DNA in 3 hours with90-minutes <strong>of</strong> hands-on time. Deep sequencing <strong>of</strong> genomic librariesindicates that this system reduces coverage bias and GC bias, as well asimproves library diversity.153 Semiconductor Sequencing for LifeJ. Myers, J. RothbergIon Torrent, South San Francisco, CA, United StatesIon Torrent has invented the first device-a new semiconductor chipcapable<strong>of</strong> directly translating chemical signals into digital information.The first application <strong>of</strong> this technology is sequencing DNA. The deviceleverages decades <strong>of</strong> semiconductor technology advances, and in justa few years has brought the entire design, fabrication and supply chaininfrastructure <strong>of</strong> that industry-a trillion dollar investment-to bear on thechallenge <strong>of</strong> sequencing. The result is Ion semiconductor sequencing,the first commercial sequencing technology that does not use light, andas a result delivers unprecedented speed, scalability and low cost. All<strong>of</strong> these benefits are a result <strong>of</strong> applying a technology that is massivelyscalable, as proven by Moore’s Law, to a task that has traditionally usedoptics-based solutions, which work in a linear fashion: increasing capacityrequires increasing the number <strong>of</strong> signals that must be read resultingin longer run times, higher capital costs and ever more sophisticatedoptics. By contrast, Ion Torrent semiconductor technology can provideincreases in chip capacity without impacting capital costs or runtime.Ion Torrent sequencing uses only natural (label-free) reagents andtakes place in Ion semiconductor microchips that contain sensors whichhave been fabricated as individual electronic detectors, allowing onesequence read per sensor. We will show how the technology has scaledin just a few months from ~1 million sensors in the first-generationIon 314 chips to ~7 million sensors in the second-generation Ion 316chips-all while maintaining the same 1- to 2-hour runtime. We will alsodemonstrate that Ion semiconductor sequencing provides exceptionalaccuracy, long read length and scalability on a single, affordable benchtopsequencing platform.154 A Comparison <strong>of</strong> Post-DNASequencing Dye-Terminator RemovalProtocolsM. Zianni, A. McCoyThe Ohio State University, Columbus, OH, UnitedStatesCapillary electrophoresis, a method for separation <strong>of</strong> ions based upontheir size to charge ratio, remains in high demand for DNA sequencing.In the process <strong>of</strong> dideoxynucleotide terminator sequencing,unincorporated nucleotides and other contaminants remaining in thereaction mixture can cause multiple issues in the electropherograms,such as unincorporated dye peaks, missed base calls, decreased signalstrength or a complete lack <strong>of</strong> data as a result <strong>of</strong> blocked capillaries. Avariety <strong>of</strong> dye-terminator removal protocols exists to clean and purifythe sequencing reaction extension products. To determine their qualityand reproducibility, six protocols were tested with one large volumecontrol reaction aliquoted into a 96-well PCR plate. The protocolsincluded ethanol precipitation, gel filtration, and 4 solid phasereversible immobilization procedures with 1 utilizing the surface <strong>of</strong> aplate and the other 3 utilizing magnetic beads. The cleaned and purifiedsequencing reactions were processed on the 3730 DNA Analyzer(Applied Biosystems), and the contiguous read lengths, QV20+ scores,and signal strengths <strong>of</strong> the resulting sequences were analyzed withSequence Scanner v1.0 (Applied Biosystems). Based on the results fromtwo replicate rounds <strong>of</strong> testing, the gel-filtration protocol provided thelongest contiguous read lengths and highest QV20+ scores.155 Simplified Reagents and Workflowsfor Robust Sample Preparation <strong>of</strong>DNA, mRNA, and Small RNAF.J. Stewart, C.L. Hendrickson, L.M. Apone,D.B. Munafo, C.R. MeyerNew England Biolabs, Inc., Ipswich, MA, UnitedStatesAs yields <strong>of</strong> data generated by the Illumina, SOLiD, and 454sequencing platforms increase, NGS users have transitioned fromperforming multiple sequencing runs per sample to multiple samplesper sequencing run. As a result, the bottleneck in sequencing labs hastransitioned from data generation to sample preparation, necessitatingthe development <strong>of</strong> streamlined library construction workflows. Wehave developed a series <strong>of</strong> reagents to facilitate the easy preparation<strong>of</strong> numerous samples in parallel, compatible with both manual andautomated pipelines. These reagents reduce the amount <strong>of</strong> laborrequired, minimize error in reaction set up, and increase the stability <strong>of</strong>enzymes used in the construction <strong>of</strong> libraries for DNA, mRNA and SmallRNA sequencing. As a result, these reagents enable the development<strong>of</strong> robust workflows for both individual and high throughput samplepreparation.Poster Abstracts<strong>ABRF</strong> <strong>2011</strong> — Technologies to Enable Personalized Medicine • 75
- Page 7 and 8:
Meeting SponsorsThe Association of
- Page 9 and 10:
Registration ServicesRegistration S
- Page 12 and 13:
Presenter InformationPresenter Info
- Page 14 and 15:
AwardsABRF Annual Award for Outstan
- Page 16 and 17:
ABRF Robert A. Welch Outstanding Re
- Page 18 and 19:
Program-at-a-GlanceProgram-at-a-Gla
- Page 20 and 21:
Sunday, February 20 (Continued)(S1-
- Page 22 and 23:
Sunday, February 20 (Continued)(W3-
- Page 24 and 25:
Monday, February 21 (Continued)12:0
- Page 26 and 27: Tuesday, February 22 (Continued)9:0
- Page 28 and 29: Tuesday, February 22 (Continued)(W1
- Page 30 and 31: Satellite Educational Workshop Spon
- Page 32 and 33: SW2: An Introduction to Metabolomic
- Page 34 and 35: SW4: Lean Management in Core Facili
- Page 36 and 37: Plenary Session AbstractsPlenary Se
- Page 38 and 39: Scientific Session AbstractsScienti
- Page 40 and 41: Scientific SessionAbstractsstatisti
- Page 42 and 43: Scientific SessionAbstracts(S5) Hig
- Page 44 and 45: Scientific SessionAbstracts(S7-2) S
- Page 46 and 47: Workshop Session AbstractsWorkshop
- Page 48 and 49: Workshop SessionAbstractscase incor
- Page 50 and 51: Workshop SessionAbstracts(W7) Cellu
- Page 52 and 53: Workshop SessionAbstractsresolution
- Page 54 and 55: (W14-3) Galaxy Next Generation Sequ
- Page 56 and 57: Research Group Presentation Abstrac
- Page 58 and 59: Research GroupPresentation Abstract
- Page 60 and 61: Research GroupPresentation Abstract
- Page 62 and 63: Poster Session Abstracts**ABRF Post
- Page 64 and 65: Poster Abstractsglobal gene express
- Page 66 and 67: Poster Abstractsdiscussions of cont
- Page 68 and 69: Poster Abstractspossible applicatio
- Page 70 and 71: Poster Abstracts129 Bravo Automated
- Page 73 and 74: distribution. Additionally, we show
- Page 75: Illumina Genome Analyzer. PicoPlex
- Page 79 and 80: kits for Tempus TM and PAXgene® st
- Page 81 and 82: 165 Benchmarking miRNA ExpressionLe
- Page 83 and 84: Phoenix crystallography robot and a
- Page 85 and 86: Laboratory is located next door and
- Page 87 and 88: data of a Thermo Orbitrap instrumen
- Page 89 and 90: **197 Multi-Functional Superparamag
- Page 91 and 92: pattern of N-linked glycans in form
- Page 93 and 94: advantage of using two separate 15
- Page 95 and 96: allowed absolute quantitation. Comp
- Page 97 and 98: levels between the animal groups. A
- Page 99 and 100: MuDPIT, and off-gel electrophoresis
- Page 101 and 102: 237 Multi-Site Assessment of Proteo
- Page 103 and 104: with good limits of quantification
- Page 105 and 106: 249 Rapid Monoclonal Antibody Glyca
- Page 107 and 108: OOng, J. - 117PPatel, S. - 169Peake
- Page 109 and 110: AnaSpec, Eurogentec Group Booth 417
- Page 111 and 112: FASEB MARC Program Booth 4169650 Ro
- Page 113 and 114: IntegenX, Inc. Booth 2015720 Stoner
- Page 115 and 116: Nonlinear Dynamics Booth 1052530 Me
- Page 117 and 118: Roche Applied Science Booth 5009115
- Page 119 and 120: Exhibit Hall FloorplanGrand Oaks Ba
- Page 121 and 122: Exhibitor List in Booth OrderExhibi
- Page 123 and 124: This workshop will present ways to
- Page 125 and 126: Grand Oaks Ballroom,Rooms P&Q, Leve
- Page 127 and 128:
NotesNotesABRF 2011 — Technologie
- Page 129 and 130:
Tuesday, February 22 — 12:00 pm -
- Page 131 and 132:
MARCH 16-20, 2012 • DISNEY’S CO